510(k) · Cleared
ClearedMDK Multi-Applications Platform
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Quanta System Spa · GEX Powered Laser Surgical Instrument
Cleared on Jul 2, 2013 as substantially equivalent to K070805 (Quanta System Spa, 2007) and 3 other predicates after a 151-day review. Its family tree reaches back 10 generations to 1992. 38 later devices descend from it.
- Decided
- Jul 2, 2013
- Review
- 151 days
- Class
- Class II
- Product code
- GEX
- Recalls
- None
- Predicates
- 4
Its longest line of descent runs back 10 generations to K910422 (1992). 106 ancestors in all, the oldest K820106 (1982). 38 later devices descend from it, 1 citing it directly.
- Root · 10 generations backK910422 Model RD-1200 Ruby Laser SystemSpectrum Medical Technologies, Inc. · 1992
- 6 generations between
- 3 generations backK032218 Adept 1064/532/755 LaserAdept Medical Concepts · 2003
- 2 generations backK083207 Ultrawave Iii EX 1320Quanta System Spa · 2008 · Recalled
- 1 generation backK123168 Q-Plus T+ Ipl Laser SystemQuanta System Spa · 2012 · Recalled
- This deviceK130256 MDK Multi-Applications PlatformQuanta System Spa · 2013
- Descendant · cites it directly · 37 of its ownK152012 EVO platformQuanta System Spa · 2015
- Descendant · 2 generations on · 36 of its ownK160368 EVO platformQuanta System Spa · 2016
- Descendant · 3 generations on · 30 of its ownK163222 Discovery Pico FamilyQuanta System Spa · 2016
- Descendant · 4 generations on · 21 of its ownK171945 Discovery Pico, Discovery Pico PlusQuanta System Spa · 2017
- Descendant · 5 generations on · 20 of its ownK172376 Discovery Pico, Discovery Pico PlusQuanta System Spa · 2017
Show all 10 generations
- Root · 10 generations backK910422 Model RD-1200 Ruby Laser SystemSpectrum Medical Technologies, Inc. · 1992
- 9 generations backK961279 Sharplan Lasers, Inc. Ruby Laser SystemSharplan Lasers, Inc. · 1996
- 8 generations backK962446 Sharplan Ruby Laser SystemSharplan Lasers, Inc. · 1997
- 7 generations backK974536 Photoderm HR SystemEsc Medical Systems, Ltd. · 1998
- 6 generations backK991935 Epilight Hair Removal System, Photoderm HR SystemEsc Medical Systems, Ltd. · 2000
- 5 generations backK014040 Family of Altus Medical Modified Coolglide Aesthetic Lasers, Models…Altus Medical, Inc. · 2002
- 4 generations backK022226 Altus Medical Family of Coolglide Lasers, Models Coolglide I…Altus Medical, Inc. · 2002
- 3 generations backK032218 Adept 1064/532/755 LaserAdept Medical Concepts · 2003
- 2 generations backK083207 Ultrawave Iii EX 1320Quanta System Spa · 2008 · Recalled
- 1 generation backK123168 Q-Plus T+ Ipl Laser SystemQuanta System Spa · 2012 · Recalled
- This deviceK130256 MDK Multi-Applications PlatformQuanta System Spa · 2013
Showing 5 of 38 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 38 · See all- K152012EVO platformQuanta System Spa · 2015 · cites it directly37descendants
- K160368EVO platformQuanta System Spa · 2016 · 2 generations on36descendants
- K163222Discovery Pico FamilyQuanta System Spa · 2016 · 3 generations on30descendants
- K171945Discovery Pico, Discovery Pico PlusQuanta System Spa · 2017 · 4 generations on21descendants
- K172376Discovery Pico, Discovery Pico PlusQuanta System Spa · 2017 · 5 generations on20descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −10 | K910422 | Model RD-1200 Ruby Laser System | Spectrum Medical Technologies, Inc. | 1992 | — |
| −9 | K961279 | Sharplan Lasers, Inc. Ruby Laser System | Sharplan Lasers, Inc. | 1996 | — |
| −8 | K962446 | Sharplan Ruby Laser System | Sharplan Lasers, Inc. | 1997 | — |
| −7 | K974536 | Photoderm HR System | Esc Medical Systems, Ltd. | 1998 | — |
| −6 | K991935 | Epilight Hair Removal System, Photoderm HR System | Esc Medical Systems, Ltd. | 2000 | — |
| −5 | K014040 | Family of Altus Medical Modified Coolglide Aesthetic Lasers, Models Coolglide… | Altus Medical, Inc. | 2002 | — |
| −4 | K022226 | Altus Medical Family of Coolglide Lasers, Models Coolglide I, Coolglide II… | Altus Medical, Inc. | 2002 | — |
| −3 | K032218 | Adept 1064/532/755 Laser | Adept Medical Concepts | 2003 | — |
| −2 | K083207 | Ultrawave Iii EX 1320 | Quanta System Spa | 2008 | 1 |
| −1 | K123168 | Q-Plus T+ Ipl Laser System | Quanta System Spa | 2012 | 1 |
| 0 (this device) | K130256 | MDK Multi-Applications Platform | Quanta System Spa | 2013 | — |
| +1 | K152012 | EVO platform | Quanta System Spa | 2015 | — |
| +2 | K160368 | EVO platform | Quanta System Spa | 2016 | — |
| +3 | K163222 | Discovery Pico Family | Quanta System Spa | 2016 | — |
| +4 | K171945 | Discovery Pico, Discovery Pico Plus | Quanta System Spa | 2017 | — |
| +5 | K172376 | Discovery Pico, Discovery Pico Plus | Quanta System Spa | 2017 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1982 | 1 | 0 |
| 1988 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 4 | 0 |
| 1993 | 5 | 0 |
| 1994 | 8 | 0 |
| 1995 | 6 | 0 |
| 1996 | 8 | 0 |
| 1997 | 10 | 0 |
| 1998 | 6 | 0 |
| 1999 | 5 | 0 |
| 2000 | 11 | 0 |
| 2001 | 12 | 0 |
| 2002 | 13 | 0 |
| 2003 | 1 | 0 |
| 2005 | 1 | 0 |
| 2006 | 1 | 0 |
| 2007 | 1 | 0 |
| 2008 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2015 | 1 | 0 |
| 2016 | 2 | 0 |
| 2017 | 3 | 0 |
| 2018 | 2 | 0 |
| 2019 | 1 | 0 |
| 2020 | 2 | 0 |
| 2022 | 6 | 0 |
| 2023 | 1 | 0 |
| 2024 | 4 | 0 |
| 2025 | 11 | 0 |
| 2026 | 5 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GEX device
- #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (4)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K070805 | Ultrawave II EX 1320Summary page 1…ices: The MDK Multi-Applications Plafformis claimed to be substantially equivalent to the following legally marketed predicate devices: - Ultrawave 11(K070805) - Quanta System SpA - Ultrawave Ill (K083207) - Quanta System SpA - 0-Plus T (K073549) - Q… | 2007 |
| * | K083207 | Ultrawave Iii EX 1320Summary page 1…tially equivalent to the following legally marketed predicate devices: - Ultrawave 11(K070805) - Quanta System SpA - Ultrawave Ill (K083207) - Quanta System SpA - 0-Plus T (K073549) - Quanta System SpA - 0-Plus T +IPL (K123168) - Q… | 2008 |
| * | K073549 | Q-Plus TSummary page 1…e devices: - Ultrawave 11(K070805) - Quanta System SpA - Ultrawave Ill (K083207) - Quanta System SpA - 0-Plus T (K073549) - Quanta System SpA - 0-Plus T +IPL (K123168) - Quanta System Spa… | 2008 |
| * | K123168 | Q-Plus T+ Ipl Laser SystemSummary page 1…stem SpA - Ultrawave Ill (K083207) - Quanta System SpA - 0-Plus T (K073549) - Quanta System SpA - 0-Plus T +IPL (K123168) - Quanta System Spa 7-1 Performance Standards: There are no mandator… | 2012 |
What descends from it? (38)
See all 381 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K152012 | EVO platform | 2015 | 37 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 21 years and passes through 6 companies; a new generation was cleared every 1.7 years on median.
- 7 of the 106 ancestors have a recall of any class.
- Of its descendants, K152012 (Quanta System Spa, 2015) has gone furthest, with 37 descendants of its own.
- 3 other devices also cite its predicate K070805.
How does its category compare?
All GEX devicesGEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.
FDA decisions per year · GEX
83in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GEX
90in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GEX
3in 2024
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · GEX
2,720in 2025
MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 73 | 79 | 9 | 342 |
| 2008 | 107 | 86 | 2 | 232 |
| 2009 | 69 | 100 | 0 | 209 |
| 2010 | 50 | 96 | 4 | 1,711 |
| 2011 | 41 | 83 | 18 | 3,024 |
| 2012 | 45 | 118 | 5 | 2,000 |
| 2013 | 46 | 144 | 3 | 2,236 |
| 2014 | 61 | 147 | 6 | 2,036 |
| 2015 | 47 | 112 | 0 | 2,099 |
| 2016 | 51 | 114 | 1 | 2,585 |
| 2017 | 67 | 90 | 5 (1) | 2,977 |
| 2018 | 51 | 78 | 5 | 3,525 |
| 2019 | 41 | 88 | 6 | 2,709 |
| 2020 | 52 | 90 | 1 | 2,183 |
| 2021 | 53 | 123 | 0 | 3,465 |
| 2022 | 60 | 152 | 0 | 2,288 |
| 2023 | 52 | 87 | 6 | 2,337 |
| 2024 | 82 | 90 | 3 | 2,187 |
| 2025 | 83 | 90 | 0 | 2,720 |
| 2026 | 57 | 90 | 2 | — |
What is it indicated for?
The MDK Multi-Applications Platform is intended for use in aesthetic, cosmetic and surgical application requiring incision, excision, ablation, vaporization and coagulation of body soft tissues in the medical specialties of dermatology, general and plastic surgery, endoscopic/laparoscopic general surgery, gastroenterology, gynecology, otorhinolaryngology (ENT), neurosurgery, oral surgery as follows: Nd:YAG 1064nm Q-switched and 532nm Q-switched The MDK…
Read the full statement (1,122 words)
The MDK Multi-Applications Platform is intended for use in aesthetic, cosmetic and surgical application requiring incision, excision, ablation, vaporization and coagulation of body soft tissues in the medical specialties of dermatology, general and plastic surgery, endoscopic/laparoscopic general surgery, gastroenterology, gynecology, otorhinolaryngology (ENT), neurosurgery, oral surgery as follows:
Nd:YAG 1064nm Q-switched and 532nm Q-switched
The MDK Multi-Applications Platform is intended for treatment of vascular lesions, pigmented lesions, and for hair, tattoo removal and the incision, excision, ablation, vaporization of soft tissue.
(ablation, vaporization, incision, excision and coagulation of soft tissue) indicated for treatment such as, but not limited to treatment of:
Tattoo removal
1064nm: suggested for dark blue and black ink
532nm: suggested for red, orange, yellow, and purple ink
Pigmented lesion removal (benign)
Cafe au lait spot
Ephelides, solar lentigo (lentigines)
Becker Nevus
retNevus
Nevus spilus
Nd:YAG 1064nm (long & short Pulse)
The MDK Multi-Applications Platform is intended for general surgical applications; dermatology/plastic surgery; endoscopic-laparoscopic surgery; general surgery; gynecology; ENT; hemostasis; neurosurgery and orthopedics; pulmonary surgery; thoracic surgery, urology; and orthopedics.
General Surgical Applications:
Incision, excision, coagulation, hemostasis, vaporization, and/or ablation of soft tissue in dermatology & plastic surgery, endoscopic, laparoscopic general surgery, gastroenterology, general surgery, gynecology, head and neck/otorhinolaryngology (ENT), neurosurgery, oculoplastic, orthopedics, pulmonary surgery, thoracic surgery and urology.
Dermatology/plastic surgery
Coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venous lake, leg and spider veins and poikiloderma of Civatte and treatment of benign cutaneous lesions such as warts, scars, striae and psoriasis. In addition, the laser is intended for the treatment of benign pigmented lesions such as, but not limited to, vitiligo (white spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratoses, tattoos (significant reduction in the intensity of blue and/or black tattoos), and plaques.
The laser is also indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment and for patients with lesions that have not responded to other laser treatments.
The laser is also indicated for the treatment of facial wrinkles.
It is indicated for the removal of unwanted hair, for the stable long-term, or permanent, hair reduction through selective targeting of melanin in hair follicles, and for the treatment of pseudofolliculitis barbae (PFB). Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime.
It is indicated for the reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar.
It is indicated for use on all skin types (Fitzpatrick I-VI) including tanned skin, and the removal and permanent reduction of unwanted hair in Fitzpatrick I-VI, including suntanned skin types.
Orthopedics
Cutting, ablation, and/or hemostasis of intra-articular tissue in orthopedic surgical and arthroscopic applications.
Palliative treatment of benign and malignant pulmonary airway obstructions, including squamous cell carcinoma, adenocarcinoma, carcinoid, benign tumors, granulomas, and benign strictures.
Nd:YAG 1064nm (long & short Pulse) - Continued
Thoracic Surgery
Incision, excision, coagulating and vaporization of soft tissue. Thoracic applications, including but not limited to, isolation of vessels for endarterectomy and/or by-pass graft, wedge resections, thoracotomy, formation of pacemaker pockets; vaporization, coagulation, incision/excision, debulking, and ablation of lung tissue (thoracoscopy).
All applications including superficial urinary bladder tumors, invasive bladder carcinoma, urethral strictures and lesions of the external genitalia (including condyloma acuminata).
Indicated for use in general surgery and dermatology for the incision, excision, ablation, vaporization, coagulation and hemostasis of soft tissue. It is also indicated for the treatment of periorbital and perioral wrinkles, fine lines and wrinkles, and the treatment of back acne and atrophic acne scars.
Alexandrite 755 nm
Intended for coagulation and hemostasis of vascular lesions and the removal and permanent reduction of unwanted hair in Fitzpatrick skin type I-VI, including suntanned skin types. Also indicated for pigmented lesions and wrinkles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime.
For the coagulation and hemostasis of vascular lesions,
Plastic Surgery
For photocoagulation and hemostasis of vascular and cutaneous lesions in dermatology including but not limited to, the following general categories: vascular lesions [angiomas, hemangiomas (port wine), telangiectasia (facial or extremities telangiectasias, venous anomalies, leg veins] benign pigmented lesions (nevi, lentigines, chloasma, cafe au-lait, tattoos (red and green ink), verrucae, skin tags, keratoses, plaques, cutaneous lesion treatment (hemostasis, color lightening, blanching, flattening, reduction of lesion size).
General Surgery:
Vaporizing, coagulating, incising, excising, debulking, and ablating of soft tissue as well as in endoscopic (e.g., laparoscopic) or open surgeries.
Gastroenterology:
Tissue ablation and hemostasis in the gastrointestinal tract; esophageal neoplastic obstructions, including squamous cell carcinoma and adenocarcinoma; gastrointestinal hemostasis (including varices, esophageal ulcer, Mallory-Weiss tear, gastric ulcer, angiodysplasia, stomal ulcers, non-bleeding ulcers, gastric erosions), gastrointestinal tissue ablation (benign and malignant neoplasm, angiodysplasia, polyps, ulcer, colitis, hemorrhoids).
Head and Otorhinolaryngology (ENT):
Tissue incision, excision, ablation, and vessel hemostasis.
Hemostasis during Surgery:
Adjunctive coagulation and hemostasis (bleeding control) during surgery in endoscopic (e.g., laparoscopic) and open surgery.
Neurosurgery:
Hemostasis for: Pituitary Tumor, Meningioma; hemangioblastoma; AVMs; Glioma; Glioblastoma; Astrocytoma; Oligodendroglioma.
Ophthalmology:
Post-vitrectomy endophotocoagulation of the retina.
Nd:YAG 632nm (long pulse) - continued
Pulmonary Surgery
Palliative treatment of benign and malignant pulmonary airway obstructions, including squamous cell carcinoma, adenocarcinoma; carcinoid; benign tumors; granulomas; benign strictures.
Thoracic Surgery
Cutting (incision and ablation), coagulating, and vaporizing of soft tissue. Thoracic applications including, but not limited to: isolation of vessels for endarterectomy and/or by-pass graft, wedge resections, thoracotomy, formation of pacemaker pockets. Vaporization, coagulation, incision and excision, debulking, and ablation of lung tissue (thoracoscopy).
All applications including: superficial urinary bladder tumors, invasive bladder carcinoma; urethral strictures; lesions of the external genitalia (including condyloma acuminata).
IPL 590-1200nm; 626-1200nm; 650-1200nm
Indicated for permanent hair removal.
Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime.
IPL 560-1200nm; 570-1200nm
Indicated for photocoagulation of dermatological vascular lesion (i.e. face telangiectasia), photothermolysis of blood vessels (beam of facial and leg veins), and treatment of benign pigmented lesions.
IPL 400-1200nm
Indicated for inflammatory acne (acne vulgaris).
Integrated Skin Cooler
The intended use of the integrated cooling system in the MDK Multi-Applications Platform hand-piece is to provide cooling of the skin prior to laser treatment, for the reduction of pain during laser treatment, to allow for the use of higher fluencies for laser treatments such as hair removal and vascular lesion, and to reduce the potential side effects of laser treatment.
Any other different use is considered incorrect.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K130256 · printed Nov 6, 2026
Cite this page
510(k) Report. “K130256: MDK Multi-Applications Platform.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K130256
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026